ライフサイエンスコーパス: BDI

1 BDI is the most common serious complication of laparosco

2 BDI scores >/=10 were reported in four of the 72 women (

3 BDI scores, however, significantly predicted increased m

4 (BDI)Zn-1 also enables controlled copolymerization of OCA

5 (BDI-2)ZnN(SiMe(3))(2) inserts CO(2) and eliminates trime

6 [(BDI-2)ZnOMe](2) [(BDI-2) = 2-((2,6-diethylphenyl)amido)-

7 [(BDI-7)Zn(mu-OAc)](2) [(BDI-7) = 3-cyano-2-((2,6-diethylp

8 of (BDI-IE)Zn(OCH(CH3 )COOCH3 ) ((BDI)Zn-1, (BDI-IE)=2-((2,6-diethylphenyl)amino)-4-((2,6-diisopropyl

9 e rhenium(II) complex Re(eta(5)-Cp)(BDI) (1; BDI = N,N'-bis(2,6-diisopropylphenyl)-3,5-dimethyl-beta-

10 t)Bu)](2)(mu-RC(6)H(5))][B(C(6)F(5))(4)](2) (BDI(#) = (ArNC(Me))(2)CH(2)).

11 [(BDI-7)Zn(mu-OAc)](2) [(BDI-7) = 3-cyano-2-((2,6-diethylphenyl)amido)-4-((2,6-di

12 [(BDI-2)ZnOMe](2) [(BDI-2) = 2-((2,6-diethylphenyl)amido)-4-((2,6-diethylphe

13 A total of 200 BDI patients [age 54(20-83); 64 male], followed up for m

14 Test (RAVLT), Beck Depression Inventory-21 (BDI-21), and World Health Organization Quality of life-B

15 er complex {(Cu(BDI(Mes)))(2)(mu-C(6)H(6))} (BDI(Mes) = N,N'-bis(2,4,6-trimethylphenyl)pentane-2,4-di

16 ated cationic inverted sandwich complex 8 [[(BDI(#))Nb(N(t)Bu)][(BDI)Nb(N(t)Bu)](mu-C(6)H(5))][B(C(6)

17 e deterioration (increase >/=8 HAM-D or >/=9 BDI points), extreme nonresponse (posttreatment HAM-D sc

18 (6)F(5))(4)] and the dicationic complex 9 [[(BDI(#))Nb(N(t)Bu)](2)(mu-RC(6)H(5))][B(C(6)F(5))(4)](2)

19 larger proportion of remissions defined as a BDI-II score </=8 (68.3% compared with 44.5%) compared w

20 prospective database of all patients with a BDI following LC was maintained.

21 in one-pot reactions utilizing a Lewis acid BDI(CF3)-Zn-N(SiMe3)2 (1) catalyst.

22 Immediate and early repair after BDI results in comparable, if not better long-term outco

23 lectronic structure in a series of (BDI)Al, (BDI)AlX2, and (BDI)AlR2 coordination compounds (X = F, C

24 The monocation and dication analogues {[(BDI)(N(t)Bu)Nb]2(mu-eta(3):eta(3)P4)}{B(Ar(F))4}n (5, n

25 ciation between pgACC-dlPFC connectivity and BDI.

26 orsening in UMSARS, RBDsq, MDS-UPDRS III and BDI scores at the 6-year follow-up compared with baselin

27 at 6 years in UPSIT, MoCA, MDS-UPDRS III and BDI.

28 and mood assessments using the PRIME-MD and BDI instruments were performed at baseline, right after

29 ioxidant according to B-ALP, MPO, RANKL, and BDI values (P <0.05).

30 sion severity measured with the SIGH-SAD and BDI-II improved significantly and comparably with CBT-SA

31 4D Flow MRI based quantification of TVSS and BDI which are closely linked to blood damage.

32 ons about the aluminum atoms in (BDI)Al and (BDI)AlH2 are similar relative to the (BDI)AlX2 and (BDI)

33 For (BDI)Al and (BDI)AlH2 the experimental Al K-edge XANES spectra and sp

34 2 are similar relative to the (BDI)AlX2 and (BDI)AlMe2 compounds, despite having different formal oxi

35 formally trivalent compounds (BDI)AlX2 and (BDI)AlR2.

36 ture in a series of (BDI)Al, (BDI)AlX2, and (BDI)AlR2 coordination compounds (X = F, Cl, I; R = H, Me

37 4-((2,6-diethylphenyl)imino)-2-pentene] and (BDI-1)ZnO(i)Pr [(BDI-1) = 2-((2,6-diisopropylphenyl)amid

38 (mu-OMe)(mu,eta(2)-O(2)COMe)Zn(BDI-2)] and [(BDI-1)Zn(mu,eta(2)-O(2)CO(i)Pr)](2), respectively.

39 ) at 50 degrees C using [(BDI-1)ZnOAc] and [(BDI-2)ZnOAc] show orders in [Zn](tot) of 1.73 +/- 0.06 a

40 e complexes {(BDI(Mes))CuAl(BDI(Dip))} and {(BDI(Mes))CuGa(BDI(Dip))}.

41 r is first order in both monomer as well as (BDI-1)ZnO(i)()Pr concentration.

42 A race by baseline BDI-II interaction was observed (P=0.003) in which eleva

43 ontrolling for baseline depression (baseline BDI HR: 1.1, 95% CI: 1.06 to 1.14, p < 0.001) and establ

44 y centre and minimised according to baseline BDI score, whether the general practice had a counsellor

45 rhenium(I) compound, Na[Re(eta(5)-Cp)(BDI)] (BDI = N, N'-bis(2,6-diisopropylphenyl)-3,5-dimethyl-beta

46 mophore, a benzylidenedimethylimidazolinone (BDI) dye, is nearly nonfluorescent (Phif < 0.001) in com

47 here was no differential association between BDI-II change and outcomes in blacks versus whites.

48 o examine the etiological boundaries between BDI and BDII by assessing their familial aggregation/coa

49 Our results suggest a distinction between BDI and BDII in etiology, partly due to genetic differen

50 inhibitor encoding the double bromodomains (BDI/II) of Brd4 can competitively dissociate endogenous

51 ed sandwich complex 8 [[(BDI(#))Nb(N(t)Bu)][(BDI)Nb(N(t)Bu)](mu-C(6)H(5))][B(C(6)F(5))(4)] and the di

52 lf-report of depressive symptoms assessed by BDI-II score (range 0-63), analysed by intention to trea

53 11 of these were significantly depressed by BDI criteria.

54 tients with more breathlessness (measured by BDI and VAS for breathing) and more abnormal physiologic

55 romatin and that replacing Brd4 molecules by BDI/II causes abnormal nucleosome aggregation and chroma

56 ccording to kinetic studies, propagation by (BDI-1)ZnO(i)()Pr is first order in both monomer as well

57 However, when comparing BDI and BDII patients directly, we did not detect any si

58 6-Me2C6H3) yields the eta2-ketimine complex (BDI)(Me2C=NXyl)Nb(NCMe3), whose characterization and rea

59 beta-diketiminato dimethyl niobium complex (BDI)Me2Nb(NtBu) is shown to lead to a variety of product

60 niobium inverted arene sandwich complexes [[(BDI)Nb(N(t)Bu)](2)(mu-RC(6)H(5))] (7a: R = H and 7b: R =

61 iminate) in toluene afforded the complexes {(BDI(Mes))CuAl(BDI(Dip))} and {(BDI(Mes))CuGa(BDI(Dip))}.

62 om that of the formally trivalent compounds (BDI)AlX2 and (BDI)AlR2.

63 o-ethene-dechlorinating bacterial consortium BDI-SZ containing Dehalococcoides mccartyi (Dhc) strains

64 OR,1.63;95%CI,1.05-2.54;P = .03); continuous BDI-II score (OR, 1.19; 95%CI, 0.95-1.49; P = .14); GAD

65 In contrast, (BDI-2)ZnO(i)()Pr [(BDI-2) = 2-((2,6-diethylphenyl)amido)

66 rt the use of (BDI-IE)Zn(OCH(CH3 )COOCH3 ) ((BDI)Zn-1, (BDI-IE)=2-((2,6-diethylphenyl)amino)-4-((2,6-

67 he Cp ligand in the cation, [ORe(eta(5) -Cp)(BDI)](+) (3(+) ), which allows for nucleophilic attack b

68 ies of the rhenium(II) complex Re(eta(5)-Cp)(BDI) (1; BDI = N,N'-bis(2,6-diisopropylphenyl)-3,5-dimet

69 mple of a rhenium(II) compound Re(eta(5)-Cp)(BDI) (2), while protonation of 1 yields the rhenium(III)

70 henium(III) hydride complex Re(H)(eta(5)-Cp)(BDI) (3).

71 nionic rhenium(I) compound, Na[Re(eta(5)-Cp)(BDI)] (1; Cp = cyclopentadienide, BDI = N, N'-bis(2,6-di

72 nionic rhenium(I) compound, Na[Re(eta(5)-Cp)(BDI)] (BDI = N, N'-bis(2,6-diisopropylphenyl)-3,5-dimeth

73 istances in 1.L relative to Na[Re(eta(5)-Cp)(BDI)] was observed in the solid-state and reproduced in

74 THF and the anionic fragment, [Re(eta(5)-Cp)(BDI)](-).

75 2 and the zinc(I) compound [ZnRe(eta(5)-Cp)(BDI)](2) (4), which features a linear, tetrametallic Re(

76 ed zinc(II) complex [(mu-OTf)ZnRe(eta(5)-Cp)(BDI)](2) (5, OTf = trifluoromethanesulfonate).

77 per(I) beta-diketiminate copper complex {(Cu(BDI(Mes)))(2)(mu-C(6)H(6))} (BDI(Mes) = N,N'-bis(2,4,6-t

78 luene afforded the complexes {(BDI(Mes))CuAl(BDI(Dip))} and {(BDI(Mes))CuGa(BDI(Dip))}.

79 BDI(Mes))CuAl(BDI(Dip))} and {(BDI(Mes))CuGa(BDI(Dip))}.

80 eta(5)-Cp)(BDI)] (1; Cp = cyclopentadienide, BDI = N, N'-bis(2,6-diisopropylphenyl)-3,5-dimethyl-beta

81 on (CDI) and battery electrode deionization (BDI) systems because they can achieve selective ion remo

82 Finally, we demonstrated BDI with significant improvement, up to 3 times higher p

83 pared with patients that were not depressed (BDI < 10; n = 96).

84 rimary outcome was recovery from depression (BDI score <10) at 4 months.

85 43 (38%) patients recovered from depression (BDI score <10) in the intervention group versus 23 (24%)

86 Measures of depression (BDI-II), anxiety (STAI-T) and trauma-related symptoms (T

87 played mild, moderate, or severe depression (BDI) (n = 37, 26.7%); mild, moderate, or severe anxiety

88 A series of zinc beta-diiminate (BDI) complexes and their solid-state structures, solutio

89 um(III) and tantalum(III) beta-diketiminate (BDI) tert-butylimido complexes to produce the bridging c

90 tiation of ROP in comparison to the dimeric (BDI)Zn complex.

91 for 35 adolescents with bipolar I disorder (BDI) and 37 healthy adolescents.

92 ertainty remains whether bipolar I disorder (BDI) and bipolar II disorder (BDII) differ etiologically

93 Doxo/(BDI)ZnN(TMS)(2)-mediated LA polymerizations yielded Doxo

94 ydride (SA) to mimic the initiation of Doxo/(BDI)ZnN(TMS)(2)-mediated LA polymerization, Doxo-14-succ

95 known as nanoconjugates (NCs), through Doxo/(BDI)ZnN(TMS)(2)-mediated [(BDI) = 2-((2,6-diisopropylphe

96 When Doxo/(BDI)ZnN(TMS)(2) was mixed with 1-pyrenemethanol (Pyr-OH)

97 When Doxo/(BDI)ZnN(TMS)(2) was mixed with succinic anhydride (SA) t

98 he Beck Depression Inventory-Second Edition (BDI-II), remission status based on severity cutoff score

99 nd Beck Depression Inventory-Second Edition (BDI-II, administered before treatment, at week 3, and af

100 3),GAD(OR, 2.47; 95%CI, 1.23-4.97), elevated BDI-II (OR, 1.81; 95%CI, 1.20-2.73), elevated HADS-A sco

101 4%] had comorbidity);220(27.4%) had elevated BDI-II [Beck Depression Inventory II] scores (14), and 3

102 (2.0% compared to 9.8% in the TAU group for BDI-II category change).

103 The heritabilities for BDI and BDII were estimated at 57% (95% CI 32%-79%) and

104 The heritability for BDI and BDII and the genetic correlation across psychiat

105 schizophrenia, showed different patterns for BDI and BDII.

106 between treatment trajectories over time for BDI and GDS.

107 For (BDI)Al and (BDI)AlH2 the experimental Al K-edge XANES sp

108 the higher transition energies observed for (BDI)AlX2 systems with more electronegative X(1-) ligands

109 s in [Zn](tot) ranging from 1.0 to 1.8 for [(BDI)ZnOAc] complexes.

110 tion mechanism, where complexes of the form (BDI-1)ZnOCH(Me)CH(2)CO(2)R are the active species.

111 mino)-2-penten e] react with CO(2) to form [(BDI-2)Zn(mu-OMe)(mu,eta(2)-O(2)COMe)Zn(BDI-2)] and [(BDI

112 eta-diketiminates M(BDI(Dip)) (M = Al or Ga; BDI(Dip) = N,N'-bis(2,6-diisopropylphenyl)pentane-2,4-di

113 iminates trimethylsilyl isocyanate to give [(BDI-2)Zn(mu-OSiMe(3))](2).

114 y entry was 8, with 28% of the sample having BDI-II scores of 14 or higher.

115 rs were divided into groups with low or high BDI, based on a clinically relevant histological grading

116 r in livers with low BDI, compared with high BDI.

117 mptoms of depression, as indicated by higher BDI scores over a 1-year interval (1-point BDI change ha

118 However, (BDI)Al was unique in that it exhibited a low-energy feat

119 e outpatients with a diagnosis of BD type I (BDI) or BD type II (BDII), predominantly in a depressed

120 ssion with the Beck Depression Inventory II (BDI-II) and psychiatric interview (Diagnostic and Statis

121 everity on the Beck Depression Inventory II (BDI-II) at post treatment.

122 completed the Beck Depression Inventory II (BDI-II) score were randomized (1:1) between April 2003 a

123 tests and the Beck Depression Inventory II (BDI-II).

124 The Beck Depression Inventory-II (BDI), Beck Anxiety Inventory (BAI), The Parental Stress

125 everity on the Beck Depression Inventory-II (BDI-II) and remission on the PHQ-9.

126 scores on the Beck Depression Inventory-II (BDI-II) and the Beck Scale for Suicidal Ideation (BSSI).

127 ssessed by the Beck Depression Inventory-II (BDI-II) at baseline and after 3 months with all-cause mo

128 f-administered Beck Depression Inventory-II (BDI-II), National Eye Institute Visual Function Question

129 y employed the Beck Depression Inventory-II (BDI-II), the Hospital Anxiety and Depression Scale (HADS

130 ated (CGI) and Beck Depression Inventory-II (BDI-II).

131 the quality of the Bragg-diffraction image (BDI).

132 However, EPO improved BDI (P=0.02) and WHOQOL-BREF (P=0.01), and this was main

133 -0.42) and -3.65 (95% CI, -6.18 to -1.12) in BDI-II scores in favor of CBT vs TAU and TC, respectivel

134 opmental abnormalities during adolescence in BDI in anterior cortices, including altered developmenta

135 eived EUC alone (adjusted mean difference in BDI-II score = -4.45; 95% CI -7.26, -1.63; p = 0.002) an

136 In blacks, an increase in BDI-II score from baseline to 3 months was associated wi

137 11; P = .91) or response (> 50% reduction in BDI-II from baseline: placebo, 49.0% vs omega-3, 47.7%;

138 of participants achieving a 50% reduction in BDI-II in the GSH-CBT arm.

139 aintained at levels similar to those seen in BDI control rats.

140 e distributions about the aluminum atoms in (BDI)Al and (BDI)AlH2 are similar relative to the (BDI)Al

141 In bile duct-incannulated (BDI) rats, bile duct obstruction present for 7 days was

142 TVSS), which is used for blood damage index (BDI) estimation, was not severely affected by SNR and vo

143 resses and corresponding blood damage index (BDI) in stenotic turbulent blood flow.

144 ppa B ligand (RANKL) and bone density index (BDI) were determined stereologically in the bone section

145 thlessness, Mahler's baseline dyspnea index (BDI) and a visual analog scale (VAS) for breathing, were

146 An exploratory comparison of individual BDI-II items indicated that the Met allele was associate

147 one (BVL) using the zinc alkoxide initiator (BDI-1)ZnO(i)()Pr [(BDI-1) = 2-((2,6-diisopropylphenyl)am

148 A majority of bile duct injuries (BDI) sustained during laparoscopic cholecystectomy requi

149 n the incidence of major bile duct injuries (BDI).

150 stry for the assessment of bile duct injury (BDI).

151 -and-death (BD), birth-death-and-innovation (BDI), equal rates (ER), symmetric (SYM), general time-re

152 s with depression (Beck Depression Inventory BDI-II score >/= 20) were recruited from 27 primary care

153 and completed the Beck Depression Inventory (BDI) and 36-Item Short Form Health Survey (SF-36) annual

154 14 or more on the Beck depression inventory (BDI) and a confirmed diagnosis of depression were recrui

155 easured using the Beck depression inventory (BDI) and a daily rating scale measuring the severity of

156 nts completed the Beck Depression Inventory (BDI) at ages 61.5 years (time 1) and 63.4 years (time 2)

157 ymptoms using the Beck Depression Inventory (BDI) at baseline and again 1 year later.

158 who completed the Beck Depression Inventory (BDI) at baseline and were followed over 5.9 years.

159 ssessed using the Beck Depression Inventory (BDI) during hospitalization and at 1 and 3 months after

160 xpressed on the Beck's Depression Inventory (BDI) scale (range 0-63, higher values indicate more depr

161 pression with the Beck Depression Inventory (BDI) scale in 291 patients with CHF hospitalized as a re

162 as indicated by a Beck Depression Inventory (BDI) score > or = 10 (n = 47) showed attenuated FMD (p =

163 analyses against Beck Depression Inventory (BDI) scores in patients, and then by comparing cLBP pati

164 m Scale (PSS) and Beck Depression Inventory (BDI) to indirectly assess a latent phenotype of interest

165 The Beck Depression Inventory (BDI) was administered to 11 patients with MS and 22 heal

166 sion (Ham-D), the Beck depression inventory (BDI), and adverse events.

167 Form 36 (SF-36), Beck Depression Inventory (BDI), and one additional suicide question.

168 t Form-36 and the Beck Depression Inventory (BDI), as well as suicide items from the Symptom Checklis

169 le (HAM-D) and/or Beck Depression Inventory (BDI).

170 ssion (HAM-D) and Beck Depression Inventory (BDI).

171 ionnaire, and the Beck Depression Inventory (BDI).

172 DS-UPDRS III) and Beck Depression Inventory (BDI).

173 n Scale (GDS) and Beck Depression Inventory (BDI; defined as a 50% reduction in symptoms from baselin

174 ressive symptoms (Beck Depression Inventory [BDI-II] score >/=14 and met ICD-10 depression criteria).

175 s for >/=6 weeks, Beck depression inventory [BDI] score >/=14 and international classification of dis

176 [QIDS-SR] or the Beck Depression Inventory [BDI]), obtained for up to 1 week after ketamine administ

177 e was significantly lower in livers with low BDI, compared with high BDI.

178 dentify transplantable liver grafts with low BDI.

179 owing cutoff values were associated with low BDI: biliary bicarbonate greater than 18 mmol/L (P = 0.0

180 w-valent group 13 metal beta-diketiminates M(BDI(Dip)) (M = Al or Ga; BDI(Dip) = N,N'-bis(2,6-diisopr

181 years, 200 patients were treated for a major BDI following LC.

182 tin(II) isopropyl-(S)-lactate complex, ((Me)BDI(DIPP))SnOCH(Me)COO(i)Pr (14), has been synthesized a

183 the propagating species by treatment of ((Me)BDI(DIPP))Sn(NMe(2)) with isopropyl-(S)-lactate.

184 )Bu)(R-C(6)H(5))] (2a: R = H and 2b: R = Me, BDI = N,N'-diisopropylbenzene-beta-diketiminate) were sy

185 dination compounds (X = F, Cl, I; R = H, Me; BDI = 2,6-diisopropylphenyl-beta-diketiminate).

186 Mean BDI scores or odds for having mild to severe BDI scores,

187 Mean BDI-II scores were lower in the GSH-CBT group at 4 month

188 .5-51.1]), the intervention group had a mean BDI-II score of 19.2 (SD 13.8) compared with a mean BDI-

189 score of 19.2 (SD 13.8) compared with a mean BDI-II score of 23.4 (SD 13.2) for the usual care group

190 h the 12-month follow-up (difference in mean BDI-II score between 3 and 12 months = -0.34; 95% CI -2.

191 are, aerobic exercise resulted in lower mean BDI-II scores at 3 months (aerobic exercise, 8.95; 95% C

192 ot stressful events in midlife, and the mean BDI score (average of time 1 and time 2) or mild to seve

193 y (Trait-A) were identical at 33.5; the mean BDI score was 8.7+/-7.6.

194 The median BDI-II score at study entry was 8, with 28% of the sampl

195 s), through Doxo/(BDI)ZnN(TMS)(2)-mediated [(BDI) = 2-((2,6-diisopropylphenyl)amido)-4-((2,6-diisopro

196 luences the ROP of OCAs, with the monomeric (BDI)Zn-1 possessing superior catalytic activity for the

197 Monometallic niobium arene complexes [Nb(BDI)(N(t)Bu)(R-C(6)H(5))] (2a: R = H and 2b: R = Me, BDI

198 P of liver grafts are accurate biomarkers of BDI and can be easily determined point of care, making t

199 end-ischemic NMP to determine biomarkers of BDI.

200 When the steric bulk of BDI was reduced or when the BDI ligand was removed, sign

201 iomarkers were correlated with the degree of BDI.

202 ce reporting the perioperative management of BDI following LC.

203 ts regarding the perioperative management of BDI.

204 pared with the general population, the OR of BDI was 17.0 (95% confidence interval [CI] 13.1-22.0) in

205 en comparing the 75th and 25th percentile of BDI-II (score of 15 and 5, respectively).

206 s for safe cholecystectomy and prevention of BDI.

207 increasing charge may improve the quality of BDI further.

208 [CI] 13.1-22.0) in first-degree relatives of BDI patients, higher than that of BDII patients (OR 9.8,

209 ts and 9.8 (95% CI 7.7-12.4) in relatives of BDI patients.

210 s) were used to measure the relative risk of BDI and BDII in relatives of individuals diagnosed with

211 The push-pull substitution of BDI also leads to sensitive fluorescence-quenching respo

212 The mean interval from the time of BDI to referral was 29.1 weeks (median 3 weeks).

213 natively synthesized upon hydrogenolysis of (BDI)Nb(N(t)Bu)Me2 in the presence of P4.

214 itiator to polymerize LA in the presence of (BDI)ZnN(TMS)(2), the polymerization was complete within

215 Furthermore, the reaction of (BDI)Me2Nb(NCMe3) with XylNC (Xyl = 2,6-Me2C6H3) yields t

216 o probe electronic structure in a series of (BDI)Al, (BDI)AlX2, and (BDI)AlR2 coordination compounds

217 The use of (BDI)MgN(TMS)(2) in such a reaction also resulted in redu

218 Herein, we report the use of (BDI-IE)Zn(OCH(CH3 )COOCH3 ) ((BDI)Zn-1, (BDI-IE)=2-((2,6

219 response (posttreatment HAM-D score >/=21 or BDI score >/=31), superior improvement (HAM-D or BDI dec

220 t had at least a 50% improvement in Ham-D or BDI at week 12 compared with the placebo group; patients

221 score >/=31), superior improvement (HAM-D or BDI decrease >/=95%), and superior response (posttreatme

222 ferences between CBT and ADM on the HAM-D or BDI or in response or remission.

223 of any deterioration (increase >/=1 HAM-D or BDI point), reliable deterioration (increase >/=8 HAM-D

224 nd superior response (posttreatment HAM-D or BDI score of 0) using multilevel models.

225 of the oxo Re(V) beta-diketiminate, OReCl2 (BDI), with various cyclopentadienide (Cp) sources has be

226 ient fashion: 15% of non-depressed patients (BDI score 0 to 4), 29% of mildly depressed patients (BDI

227 e 0 to 4), 29% of mildly depressed patients (BDI score 10 to 16), and 37% of patients with moderately

228 r BDI scores over a 1-year interval (1-point BDI change hazard ratio [HR]: 1.07, 95% confidence inter

229 3 to 0.36; t(112) = 0.11; P = .91), pre-post BDI-II scores (placebo, 14.8 vs omega-3, 16.1; 95% diffe

230 zinc alkoxide initiator (BDI-1)ZnO(i)()Pr [(BDI-1) = 2-((2,6-diisopropylphenyl)amido)-4-((2,6-diisop

231 In contrast, (BDI-2)ZnO(i)()Pr [(BDI-2) = 2-((2,6-diethylphenyl)amido)-4-((2,6-diethylphe

232 enyl)imino)-2-pentene] and (BDI-1)ZnO(i)Pr [(BDI-1) = 2-((2,6-diisopropylphenyl)amido)-4-((2,6-diisop

233 The trinuclear side product {[(BDI)NbN(t)Bu]3(mu-P12)} (3) is also identified.

234 s base adducts, (L)U[(mu-eta(5):eta(5)-Cp)Re(BDI)](3) (1.L, L = THF, 1,4-dioxane, DMAP).

235 sandwich complex, U[(mu-eta(5):eta(5)-Cp)Re(BDI)](3), which was isolated and structurally characteri

236 edefined indicators of depression remission (BDI-II < or = 8: placebo, 27.4% vs omega-3, 28.3%; odds

237 occupied molecular orbital on electron-rich (BDI)Al distinguishes its valence electronic structure fr

238 no differences in the Beck Depression Score (BDI) and Positive And Negative Affect Schedule (PANES).

239 rage of time 1 and time 2) or mild to severe BDI scores (10-63 points at time 1 and time 2), or both,

240 BDI scores or odds for having mild to severe BDI scores, or both, increased according to number of mi

241 urther, the relationship between PET signal, BDI and frontolimbic functional connectivity was evaluat

242 e the bridging cyclo-P4 phosphide species {[(BDI)(N(t)Bu)M]2(mu-eta(3):eta(3)P4)} (1, M = Nb; 2, M =

243 he tau torsion of the meta-amino-substituted BDI systems leads to a zwitterionic twisted intermediate

244 rral of patients with confirmed or suspected BDI to an experienced surgeon/multispecialty hepatobilia

245 .63; P = .02); elevated depression symptoms (BDI-II score 14)(OR,1.63;95%CI,1.05-2.54;P = .03); conti

246 n, having both elevated depressive symptoms (BDI > or =10) and a previous diagnosis of depression req

247 moderately-to-severely depressive symptoms (BDI score >16) took aspirin less than 80% of the time (p

248 least 50% reduction in depressive symptoms (BDI score) at 6 months compared with baseline.

249 subtype (BD type I or type II) revealed that BDI patients had significantly larger lateral ventricles

250 iable temperature NMR experiments show that (BDI-1)ZnO(i)()Pr is monomeric in benzene-d(6) solution.

251 The square sum of TVSS and the BDI at SNR >20 were underestimated by less than 1% and 1

252 The SF-36 complements the BDI and VAS scores for breathing in scleroderma lung dis

253 ely, with pre-to-post-surgery changes in the BDI and SF-36 Mental Component Summary (MCS) and Physica

254 Across follow-up, mean improvements in the BDI, MCS and PCS scores, were 1.9 (95%CI, 1.0-2.8), 3.1

255 hile many efforts have been devoted into the BDI chromophore engineering for fluorescence recovery, l

256 t the phosphide ring but rather involves the BDI ligand to yield {[(BDI(#))Nb(N(t)Bu)]2(mu-eta(3):eta

257 S scores (F4,8.9=20.3; P<0.001), and not the BDI-II or HADS.

258 ADRS, the HAM-D, and the QIDS-SR but not the BDI.

259 However, protonation of the BDI ligands occurred readily on treatment with [H(OEt(2)

260 ; P = .03) and a nonsignificant trend on the BDI (beta = -1.14; P = .08, statistical test for trend),

261 with clinically significant symptoms on the BDI and SF-36 Mental Health Scale were cases on the SCL-

262 Scores on the BDI and VAS for breathing were highly correlated (r = -0

263 Depression was defined as a score on the BDI of > or =10.

264 ), and continuous standardized scores on the BDI-II (OR, 1.31; 95% CI, 1.05-1.62) and the HADS-A (OR,

265 alization due to any cause and scores on the BDI-II at months 3 and 12.

266 nt difference favouring MCT was found on the BDI-II at post treatment (-5.49 [95% CI -8.90 to -2.08],

267 CBT met formal criteria for recovery on the BDI-II at post treatment (odds-ratio=2.42 [1.20 to 4.92]

268 of 0.4 points (95% CI, 0.01 to 0.72) on the BDI-II per therapy session was observed.

269 nificant treatment effects were found on the BDI-II.

270 H-SAD (47.6% and 47.2%, respectively) or the BDI-II (56.0% and 63.6%).

271 particle-hole symmetry characteristic to the BDI symmetry class stems from the distinct behaviour of

272 opological mechanical systems related to the BDI symmetry class.

273 Using the BDI method we were able to extract the divergence of the

274 Similar results were seen using the BDI.

275 e steric bulk of BDI was reduced or when the BDI ligand was removed, significant amounts of Doxo-4',1

276 olume ratio was strongly correlated with the BDI score in patients with MS (r = .86, p = .006).

277 scale was significantly correlated with the BDI-II (r = 0.67, P < 0.001), indicating its potential f

278 9% screened positive for depression with the BDI-II.

279 at is localized on Al and orthogonal to the (BDI)Al plane.

280 l and (BDI)AlH2 are similar relative to the (BDI)AlX2 and (BDI)AlMe2 compounds, despite having differ

281 One hundred eighty-eight sustained their BDI at an outside hospital.

282 The flow-through BDI system increased the recoverable energy nearly 3-fol

283 Response according to BDI also did not differ significantly (telemedicine 19 [

284 BMI was unrelated to BDI-II, STAI-T, TSC-40, or TFEQ scores.

285 e correlations between [(18)F]PBR111 uptake, BDI scores, and hippocampal functional connectivities in

286 e) and 300 psi CO(2) at 50 degrees C using [(BDI-1)ZnOAc] and [(BDI-2)ZnOAc] show orders in [Zn](tot)

287 acid transport activity compared with 1-week BDI control rats.

288 There were no differences in weekly BDI-II scores (treatment x time interaction = 0.02; 95%

289 ive to healthy adolescents, adolescents with BDI showed greater volume contraction over time in a reg

290 ly with each other (r=0.85; P<0.01) and with BDI score (State-A, r=0.52; Trait-A, r=0.59; P<0.01).

291 a Project and identify genes associated with BDI not identified using standard univariate techniques.

292 PET signal was positively associated with BDI scores in patients, and significantly elevated in pa

293 frontal and parietal regions correlated with BDI scores and [(18)F]PBR111 distribution volume ratio.

294 ntibodies were significantly correlated with BDI scores; patients with BDI-II scores of > or =14 had

295 I in relatives of individuals diagnosed with BDI (n = 4309) and BDII (n = 4178).

296 ly correlated with BDI scores; patients with BDI-II scores of > or =14 had higher serum levels of ant

297 ilable follow-up [mean 8.2 (+/- 4.3) years], BDI scores did not differ between participants with subc

298 n e] reacts with 1.0 equiv of CHO to yield [(BDI-7)Zn(mu,eta(2)-OAc)(mu,eta(1)-OCyOAc)Zn(BDI-7)].

299 t rather involves the BDI ligand to yield {[(BDI(#))Nb(N(t)Bu)]2(mu-eta(3):eta(3)P4)}[B(C6F5)4]2 (4).

300 orm [(BDI-2)Zn(mu-OMe)(mu,eta(2)-O(2)COMe)Zn(BDI-2)] and [(BDI-1)Zn(mu,eta(2)-O(2)CO(i)Pr)](2), respe

301 (BDI-7)Zn(mu,eta(2)-OAc)(mu,eta(1)-OCyOAc)Zn(BDI-7)].